This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28
A look at what's coming to Contemporary OB/GYN® this week.
The effect of eating disorders in pregnancy on neurodevelopmental risk in infants
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics partners with Afayxs to expand access to Twirla®
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
